$2.53
$0.09
(3.73%)
Quote as of 1:39 PM EST on 02/10/12
ENTREMED, INC.
NASDAQ:ENMD
Related Resources
ENMD
vs. S&P 500
|
$2.53
$0.09
(3.73%)
|
|
| Today's Open | $2.39 |
|---|---|
| Previous Close | $2.44 |
| Daily Range | $2.35 - $2.70 |
| 52-Week Range | $0.90 - $5.55 |
| Market Cap | $30.97M |
| P/E Ratio | -6.26 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 61,795 |
| Average Daily Volume | 127,970 |
| Current FY EPS | $0.00 |
ENMD Information
| Description |
|---|
| A clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
EntreMed: Low Share Count, Multiple Upcoming Catalysts
11/17/2010 by Seeking Alpha
Big Pharma Looks to Biotech for Innovation
9/12/2010 by Seeking Alpha
China Biotech Week in Review: Shanghai Pharma Plans $1.2 Billion IPO
9/12/2010 by Seeking Alpha
EntreMed Widens Loss in 2Q, Clinical Trials for Ovarian Cancer Progress
8/16/2010 by Fox Business
